339 related articles for article (PubMed ID: 22127134)
1. Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease.
Koyama M; Kuns RD; Olver SD; Raffelt NC; Wilson YA; Don AL; Lineburg KE; Cheong M; Robb RJ; Markey KA; Varelias A; Malissen B; Hämmerling GJ; Clouston AD; Engwerda CR; Bhat P; MacDonald KP; Hill GR
Nat Med; 2011 Nov; 18(1):135-42. PubMed ID: 22127134
[TBL] [Abstract][Full Text] [Related]
2. Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease.
Duffner UA; Maeda Y; Cooke KR; Reddy P; Ordemann R; Liu C; Ferrara JL; Teshima T
J Immunol; 2004 Jun; 172(12):7393-8. PubMed ID: 15187116
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of antigen presentation to T cells in murine graft-versus-host disease: cross-presentation and the appearance of cross-presentation.
Wang X; Li H; Matte-Martone C; Cui W; Li N; Tan HS; Roopenian D; Shlomchik WD
Blood; 2011 Dec; 118(24):6426-37. PubMed ID: 21963602
[TBL] [Abstract][Full Text] [Related]
4. A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease.
Tawara I; Shlomchik WD; Jones A; Zou W; Nieves E; Liu C; Toubai T; Duran-Struuck R; Sun Y; Clouthier SG; Evers R; Lowler KP; Levy RB; Reddy P
J Immunol; 2010 Oct; 185(7):3866-72. PubMed ID: 20810991
[TBL] [Abstract][Full Text] [Related]
5. Induction of acute GVHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic-derived antigen-presenting cells.
Toubai T; Tawara I; Sun Y; Liu C; Nieves E; Evers R; Friedman T; Korngold R; Reddy P
Blood; 2012 Apr; 119(16):3844-53. PubMed ID: 22101894
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of the Activation and Proliferation Kinetics and Effector Functions of Human Lymphocytes, and Antigen Presentation Capacity of Antigen-Presenting Cells in Xenogeneic Graft-Versus-Host Disease.
Kawasaki Y; Sato K; Hayakawa H; Takayama N; Nakano H; Ito R; Mashima K; Oh I; Minakata D; Yamasaki R; Morita K; Ashizawa M; Yamamoto C; Hatano K; Fujiwara SI; Ohmine K; Muroi K; Kanda Y
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1563-1574. PubMed ID: 29678638
[TBL] [Abstract][Full Text] [Related]
7. The primacy of gastrointestinal tract antigen-presenting cells in lethal graft-versus-host disease.
Koyama M; Hill GR
Blood; 2019 Dec; 134(24):2139-2148. PubMed ID: 31697827
[TBL] [Abstract][Full Text] [Related]
8. Cross-dressing by donor dendritic cells after allogeneic bone marrow transplantation contributes to formation of the immunological synapse and maximizes responses to indirectly presented antigen.
Markey KA; Koyama M; Gartlan KH; Leveque L; Kuns RD; Lineburg KE; Teal BE; MacDonald KP; Hill GR
J Immunol; 2014 Jun; 192(11):5426-33. PubMed ID: 24790149
[TBL] [Abstract][Full Text] [Related]
9. Recipient B cells are not required for graft-versus-host disease induction.
Matte-Martone C; Wang X; Anderson B; Jain D; Demetris AJ; McNiff J; Shlomchik MJ; Shlomchik WD
Biol Blood Marrow Transplant; 2010 Sep; 16(9):1222-30. PubMed ID: 20338255
[TBL] [Abstract][Full Text] [Related]
10. STING negatively regulates allogeneic T-cell responses by constraining antigen-presenting cell function.
Wu Y; Tang CA; Mealer C; Bastian D; Hanief Sofi M; Tian L; Schutt S; Choi HJ; Ticer T; Zhang M; Sui X; Huang L; Mellor AL; Hu CA; Yu XZ
Cell Mol Immunol; 2021 Mar; 18(3):632-643. PubMed ID: 33500563
[TBL] [Abstract][Full Text] [Related]
11. Chloroquine treatment affects T-cell priming to minor histocompatibility antigens and graft-versus-host disease.
Schultz KR; Bader S; Paquet J; Li W
Blood; 1995 Dec; 86(11):4344-52. PubMed ID: 7492796
[TBL] [Abstract][Full Text] [Related]
12. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
13. Donor APCs are required for maximal GVHD but not for GVL.
Matte CC; Liu J; Cormier J; Anderson BE; Athanasiadis I; Jain D; McNiff J; Shlomchik WD
Nat Med; 2004 Sep; 10(9):987-92. PubMed ID: 15286785
[TBL] [Abstract][Full Text] [Related]
14. Cellular and cytokine effectors of acute graft versus host disease.
Ferrara JL
Int J Hematol; 2002 Aug; 76 Suppl 1():195-8. PubMed ID: 12430853
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation.
Min CK; Maeda Y; Lowler K; Liu C; Clouthier S; Lofthus D; Weisiger E; Ferrara JL; Reddy P
Blood; 2004 Nov; 104(10):3393-9. PubMed ID: 15280194
[TBL] [Abstract][Full Text] [Related]
16. Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation.
Lu SX; Kappel LW; Charbonneau-Allard AM; Atallah R; Holland AM; Turbide C; Hubbard VM; Rotolo JA; Smith M; Suh D; King C; Rao UK; Yim N; Bautista JL; Jenq RR; Penack O; Na IK; Liu C; Murphy G; Alpdogan O; Blumberg RS; Macian F; Holmes KV; Beauchemin N; van den Brink MR
PLoS One; 2011; 6(7):e21611. PubMed ID: 21760897
[TBL] [Abstract][Full Text] [Related]
17. Acute graft-versus-host disease does not require alloantigen expression on host epithelium.
Teshima T; Ordemann R; Reddy P; Gagin S; Liu C; Cooke KR; Ferrara JL
Nat Med; 2002 Jun; 8(6):575-81. PubMed ID: 12042807
[TBL] [Abstract][Full Text] [Related]
18. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
[TBL] [Abstract][Full Text] [Related]
19. Plasmacytoid dendritic cells prime alloreactive T cells to mediate graft-versus-host disease as antigen-presenting cells.
Koyama M; Hashimoto D; Aoyama K; Matsuoka K; Karube K; Niiro H; Harada M; Tanimoto M; Akashi K; Teshima T
Blood; 2009 Feb; 113(9):2088-95. PubMed ID: 19144988
[TBL] [Abstract][Full Text] [Related]
20. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
Xia G; Truitt RL; Johnson BD
Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]